BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 26560447)

  • 41. STYK1 promotes epithelial-mesenchymal transition and tumor metastasis in human hepatocellular carcinoma through MEK/ERK and PI3K/AKT signaling.
    Wang Z; Qu L; Deng B; Sun X; Wu S; Liao J; Fan J; Peng Z
    Sci Rep; 2016 Sep; 6():33205. PubMed ID: 27628214
    [TBL] [Abstract][Full Text] [Related]  

  • 42. CXCL12-induced glioblastoma cell migration requires intermediate conductance Ca2+-activated K+ channel activity.
    Sciaccaluga M; Fioretti B; Catacuzzeno L; Pagani F; Bertollini C; Rosito M; Catalano M; D'Alessandro G; Santoro A; Cantore G; Ragozzino D; Castigli E; Franciolini F; Limatola C
    Am J Physiol Cell Physiol; 2010 Jul; 299(1):C175-84. PubMed ID: 20392929
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A novel antagonist of CXCR4 prevents bone marrow-derived mesenchymal stem cell-mediated osteosarcoma and hepatocellular carcinoma cell migration and invasion.
    Fontanella R; Pelagalli A; Nardelli A; D'Alterio C; Ieranò C; Cerchia L; Lucarelli E; Scala S; Zannetti A
    Cancer Lett; 2016 Jan; 370(1):100-7. PubMed ID: 26517945
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Multiple actions of the chemokine CXCL12 on epithelial tumor cells in human ovarian cancer.
    Scotton CJ; Wilson JL; Scott K; Stamp G; Wilbanks GD; Fricker S; Bridger G; Balkwill FR
    Cancer Res; 2002 Oct; 62(20):5930-8. PubMed ID: 12384559
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Chemokines and hepatocellular carcinoma.
    Huang F; Geng XP
    World J Gastroenterol; 2010 Apr; 16(15):1832-6. PubMed ID: 20397259
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Role of C-X-C chemokine ligand 12/C-X-C chemokine receptor 4 in the progression of hepatocellular carcinoma.
    Jeng KS; Jeng CJ; Jeng WJ; Chang CF; Sheen IS
    Oncol Lett; 2017 Aug; 14(2):1905-1910. PubMed ID: 28789425
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Opposing roles of CXCR4 and CXCR7 in breast cancer metastasis.
    Hernandez L; Magalhaes MA; Coniglio SJ; Condeelis JS; Segall JE
    Breast Cancer Res; 2011; 13(6):R128. PubMed ID: 22152016
    [TBL] [Abstract][Full Text] [Related]  

  • 48. β-Arrestin1 and Signal-transducing Adaptor Molecule 1 (STAM1) Cooperate to Promote Focal Adhesion Kinase Autophosphorylation and Chemotaxis via the Chemokine Receptor CXCR4.
    Alekhina O; Marchese A
    J Biol Chem; 2016 Dec; 291(50):26083-26097. PubMed ID: 27789711
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The chemokine receptors CXCR4/CXCR7 and their primary heterodimeric ligands CXCL12 and CXCL12/high mobility group box 1 in pancreatic cancer growth and development: finding flow.
    Shakir M; Tang D; Zeh HJ; Tang SW; Anderson CJ; Bahary N; Lotze MT
    Pancreas; 2015 May; 44(4):528-34. PubMed ID: 25872129
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Emodin suppresses migration and invasion through the modulation of CXCR4 expression in an orthotopic model of human hepatocellular carcinoma.
    Manu KA; Shanmugam MK; Ong TH; Subramaniam A; Siveen KS; Perumal E; Samy RP; Bist P; Lim LH; Kumar AP; Hui KM; Sethi G
    PLoS One; 2013; 8(3):e57015. PubMed ID: 23472074
    [TBL] [Abstract][Full Text] [Related]  

  • 51. S100A9 promotes the proliferation and invasion of HepG2 hepatocellular carcinoma cells via the activation of the MAPK signaling pathway.
    Wu R; Duan L; Ye L; Wang H; Yang X; Zhang Y; Chen X; Zhang Y; Weng Y; Luo J; Tang M; Shi Q; He T; Zhou L
    Int J Oncol; 2013 Mar; 42(3):1001-10. PubMed ID: 23354417
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Inhibition of chemokine (CXC motif) ligand 12/chemokine (CXC motif) receptor 4 axis (CXCL12/CXCR4)-mediated cell migration by targeting mammalian target of rapamycin (mTOR) pathway in human gastric carcinoma cells.
    Chen G; Chen SM; Wang X; Ding XF; Ding J; Meng LH
    J Biol Chem; 2012 Apr; 287(15):12132-41. PubMed ID: 22337890
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Convective forces increase CXCR4-dependent glioblastoma cell invasion in GL261 murine model.
    Cornelison RC; Brennan CE; Kingsmore KM; Munson JM
    Sci Rep; 2018 Nov; 8(1):17057. PubMed ID: 30451884
    [TBL] [Abstract][Full Text] [Related]  

  • 54. CXCL12/CXCR4 chemokine signaling in spinal glia induces pain hypersensitivity through MAPKs-mediated neuroinflammation in bone cancer rats.
    Hu XM; Liu YN; Zhang HL; Cao SB; Zhang T; Chen LP; Shen W
    J Neurochem; 2015 Feb; 132(4):452-63. PubMed ID: 25393328
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A meta-analysis for C-X-C chemokine receptor type 4 as a prognostic marker and potential drug target in hepatocellular carcinoma.
    Hu F; Miao L; Zhao Y; Xiao YY; Xu Q
    Drug Des Devel Ther; 2015; 9():3625-33. PubMed ID: 26203228
    [TBL] [Abstract][Full Text] [Related]  

  • 56. CXCL12-CXCR4/CXCR7 Axis in Colorectal Cancer: Therapeutic Target in Preclinical and Clinical Studies.
    Khare T; Bissonnette M; Khare S
    Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34298991
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Roles of the MEK1/2 and AKT pathways in CXCL12/CXCR4 induced cholangiocarcinoma cell invasion.
    Leelawat K; Leelawat S; Narong S; Hongeng S
    World J Gastroenterol; 2007 Mar; 13(10):1561-8. PubMed ID: 17461449
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Regulation of CXCR4-mediated chemotaxis and chemoinvasion of breast cancer cells.
    Fernandis AZ; Prasad A; Band H; Klösel R; Ganju RK
    Oncogene; 2004 Jan; 23(1):157-67. PubMed ID: 14712221
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Stromal-derived factor-1α/CXCL12-CXCR4 chemotactic pathway promotes perineural invasion in pancreatic cancer.
    Xu Q; Wang Z; Chen X; Duan W; Lei J; Zong L; Li X; Sheng L; Ma J; Han L; Li W; Zhang L; Guo K; Ma Z; Wu Z; Wu E; Ma Q
    Oncotarget; 2015 Mar; 6(7):4717-32. PubMed ID: 25605248
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Possible role of stromal-cell-derived factor-1/CXCR4 signaling on lymph node metastasis of oral squamous cell carcinoma.
    Uchida D; Begum NM; Almofti A; Nakashiro K; Kawamata H; Tateishi Y; Hamakawa H; Yoshida H; Sato M
    Exp Cell Res; 2003 Nov; 290(2):289-302. PubMed ID: 14567988
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.